PIK3R1 and non-Hodgkin lymphoma: In CVID published cohorts, the estimated prevalence of the direct mutation in PIK3R1 is 0.481%, with its associated phenotype being PIK3CD which is the most frequent pathogenic variant in both CVID and NHL with the prevalence of 2.674% and 6.0%, respectively (61).